Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark T Poch

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Drug Metabolism and Disposition: the Biological Fate of Chemicals|May 19, 2005
Molecular mechanisms regulating human CYP4B1 lung-selective expressionMark T Poch, N Shane Cutler, Garold S Yost, et al.
Drug Metabolism Reviews|May 9, 2008
Regulatory polymorphisms and their contribution to interindividual differences in the expression of enzymes influencing drug and toxicant dispositionRonald N Hines, Sevasti B Koukouritaki, Mark T Poch, et al.
Toxicology and Applied Pharmacology|September 15, 2004
Two distinct classes of CCAAT box elements that bind nuclear factor-Y/alpha-actinin-4: potential role in human CYP1A1 regulationMark T Poch, Loola Al-Kassim, Steven M Smolinski, et al.
Molecular Pharmacology|April 29, 2005
Discovery of novel flavin-containing monooxygenase 3 (FMO3) single nucleotide polymorphisms and functional analysis of upstream haplotype variantsSevasti B Koukouritaki, Mark T Poch, Erwin T Cabacungan, et al.
The Journal of Pharmacology and Experimental Therapeutics|October 20, 2006
Identification and functional analysis of common human flavin-containing monooxygenase 3 genetic variantsSevasti B Koukouritaki, Mark T Poch, Marilyn C Henderson, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Drug Metabolism and Disposition: the Biological Fate of Chemicals|May 19, 2005
Molecular mechanisms regulating human CYP4B1 lung-selective expressionMark T Poch, N Shane Cutler, Garold S Yost, et al.
Drug Metabolism Reviews|May 9, 2008
Regulatory polymorphisms and their contribution to interindividual differences in the expression of enzymes influencing drug and toxicant dispositionRonald N Hines, Sevasti B Koukouritaki, Mark T Poch, et al.
Toxicology and Applied Pharmacology|September 15, 2004
Two distinct classes of CCAAT box elements that bind nuclear factor-Y/alpha-actinin-4: potential role in human CYP1A1 regulationMark T Poch, Loola Al-Kassim, Steven M Smolinski, et al.
Molecular Pharmacology|April 29, 2005
Discovery of novel flavin-containing monooxygenase 3 (FMO3) single nucleotide polymorphisms and functional analysis of upstream haplotype variantsSevasti B Koukouritaki, Mark T Poch, Erwin T Cabacungan, et al.
The Journal of Pharmacology and Experimental Therapeutics|October 20, 2006
Identification and functional analysis of common human flavin-containing monooxygenase 3 genetic variantsSevasti B Koukouritaki, Mark T Poch, Marilyn C Henderson, et al.
Pageof 1